📖Complete GuideUpdated 2026🔬Evidence-Based

Vyleesi (Bremelanotide) Guide for HSDD 2026

Complete Guide & Evidence (2026)

The complete guide to Vyleesi (Bremelanotide), the FDA-approved peptide for Hypoactive Sexual Desire Disorder in women.

Dashboard
Your complete health overview in one place
🔥
14-day streak
Logged 18 of 18 scheduled shots
Next Shot Reminder
ACTIVE MEDICATIONS
VyleesiB12
VYLEESI
🔥 14
2
days away
Thursday · 7.5mg
Medication Supply
Vyleesi
6.2 / 10 mg · Vial
~42 days left · Mar 15
B12
4.4 / 5 ml · Vial
~88 days left · May 8
Retatrutide
1.2 / 5 mg · Vial
~6 days left · refill soon
Medication Levels
7 Days2 Weeks1 Month90 Days
CURRENT LEVEL
5.42mg
Mar 6
Today
ACTIVE MEDICATIONS
VyleesiRetatrutide
0mg2.7mg5.4mg
18
Total Injections
💉 All time
122/78
Average BP
🩺 mmHg
8.4
Avg Mood
😊 /10
Health Chart
1mAll
218.6lb
↓ 8.4 lb · 3.7%
WeightInjectionsBPMood
2282222162102277.5mg7.5mg4mg10mg218
Feb 6Feb 14Feb 22Mar 2Today
Photos
12 photos · 2w streak
Week 1
Week 7
Today
Scheduled Reminders
Weight
Due today
Mood
Done
Blood Pressure
Tomorrow
Body Measurements
In 3 days
Dashboard
Your complete health overview in one place
🔥
14-day streak
Logged 18 of 18 scheduled shots
Next Shot Reminder
ACTIVE MEDICATIONS
VyleesiB12
VYLEESI
🔥 14
2
days away
Thursday · 7.5mg
Medication Supply
Vyleesi
6.2 / 10 mg · Vial
~42 days left · Mar 15
B12
4.4 / 5 ml · Vial
~88 days left · May 8
Retatrutide
1.2 / 5 mg · Vial
~6 days left · refill soon
Medication Levels
7 Days2 Weeks1 Month90 Days
CURRENT LEVEL
5.42mg
Mar 6
Today
ACTIVE MEDICATIONS
VyleesiRetatrutide
0mg2.7mg5.4mg
18
Total Injections
💉 All time
122/78
Average BP
🩺 mmHg
8.4
Avg Mood
😊 /10
Health Chart
1mAll
218.6lb
↓ 8.4 lb · 3.7%
WeightInjectionsBPMood
2282222162102277.5mg7.5mg4mg10mg218
Feb 6Feb 14Feb 22Mar 2Today
Photos
12 photos · 2w streak
Week 1
Week 7
Today
Scheduled Reminders
Weight
Due today
Mood
Done
Blood Pressure
Tomorrow
Body Measurements
In 3 days
01BACKGROUND

FDA-Approved Peptide for HSDD

Vyleesi (generic name Bremelanotide, originally PT-141) is an FDA-approved injectable peptide designed to treat Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women.

02DEEP DIVE

What Is Vyleesi (Bremelanotide) Guide?

Vyleesi (generic name Bremelanotide, originally PT-141) is an FDA-approved injectable peptide designed to treat Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women.

Unlike PDE5 inhibitors (Viagra) which alter blood flow, Vyleesi works centrally in the brain by binding to melanocortin receptors, lighting up neural pathways associated with sexual arousal and desire.

03MECHANICS

Key Biohacking Mechanics

1
Non-selective agonist of melanocortin receptors (MC1R and MC4R)
2
MC4R binding directly modulates sexual responses and arousal
3
Operates on the desire phase — restoring libido, not just mechanics
4
Melanocortin pathway stimulation causes downstream dopamine release
5
Dopamine is the primary neurotransmitter for anticipation, reward, and desire
6
Effects build over 45-60 minutes post-injection
04DEEP DIVE

Dosing Protocol

SubQ injection into abdomen or thigh.

At least 45 minutes before anticipated activity.

No more than ONE dose per 24 hours, max 8 per month.

Note: Severe nausea occurs in ~40% of patients. Antiemetic medication or slow titration is often required. Do NOT exceed dose limits — it severely spikes blood pressure.

05WHAT TO TRACK

Side Effects & Safety

01
🔬
Common Effects
Nausea (40% of patients — most common). Facial flushing and warmth. Headache. Injection site reactions
02
🔬
Important Warnings
Focal hyperpigmentation if used more than 8x/month. Blood pressure elevation at higher doses. Not for use in men (off-label PT-141 is different). Skin darkening of gums, face, or breasts possible
06WHAT TO TRACK

Vital Protocol FAQs

01
🔬
Why does Vyleesi cause such bad nausea?
Because it activates melanocortin receptors everywhere, it triggers nausea centers in the brain. For many, nausea fades after a few uses, but for some it requires discontinuation.
02
🔬
Does Vyleesi work for men?
While exclusively FDA-approved for premenopausal women, the generic peptide (Bremelanotide/PT-141) is widely used in men for inducing spontaneous erections by bypassing nitric-oxide pathways.
03
Will it darken my skin?
Yes, focal hyperpigmentation was observed in trials if used more than 8 times a month, due to MC1R (tanning receptor) activation.
07FAQ

Guide FAQs

The complete guide to Vyleesi (Bremelanotide), the FDA-approved peptide for Hypoactive Sexual Desire Disorder in women.

Yes. Shotlee supports tracking Vyleesi doses, side effects, and health metrics. It is free to use.

Free · Always

Track Your Vyleesi Protocol in Shotlee

Free dose logging, side effect tracking, and health metric monitoring for your complete protocol.

📚References & sources

Start tracking